Scorpius BioManufacturing and Heat Biologics are planning to build the Scorpius Biological Services Biomanufacturing Plant in Manhattan. The plant will contain 48 bioreactors to be used for large molecule and biologics manufacturing. It is being designed by Clark Richardson & Kiskup. The builder-developers are Midwest Concrete Materials Inc. and Realty Trust Group. Construction is expected to start in November 2024 and be completed by July 2026. The project is valued at $325 million. Scorpius BioManufacturing, 1305 E. Houston St., San Antonio, Texas, 78205. DR#22-00585840.